(Q39275394)

English

Soluble inflammatory markers as predictors of virological response in patients with chronic hepatitis C virus infection treated with interferon-α plus ribavirin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Soluble inflammatory markers as predictors of virological response in patients with chronic hepatitis C virus infection treated with interferon-α plus ribavirin (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

0 references

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

Manoel Otávio da Costa Rocha

5

object named as

Manoel Otávio da Costa Rocha

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Antonio L Teixeira

1 reference

ORCID Public Data File 2021

author name string

Alexandre Sampaio Moura

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Ricardo Andrade Carmo

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Antonio Lucio Teixeira

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Mauro Martins Teixeira

4

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Memórias do Instituto Oswaldo Cruz

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

106

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

38-43

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Increased circulating and intrahepatic T-cell-specific chemokines in chronic hepatitis C: relationship with the type of virological response to peginterferon plus ribavirin combination therapy.

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin.

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Human chemokines: an update

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Scope of worldwide hepatitis C problem

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

The many roles of chemokines and chemokine receptors in inflammation

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Association of pretreatment serum interferon inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Chemokines and disease

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Noncytolytic control of viral infections by the innate and adaptive immune response

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics.

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Cytokines in viral hepatitis

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Through the looking glass: the diverse in vivo activities of chemokines

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD).

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Polymorphonuclear granulocytes enhance lipopolysaccharide‐induced soluble p75 tumor necrosis factor receptor release from mononuclear cells

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Chemokines--chemotactic cytokines that mediate inflammation

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Chemokines: what chemokine is that?

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Review article: predicting response in hepatitis C virus therapy

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Soluble inflammatory markers as predictors of liver histological changes in patients with chronic hepatitis C virus infection.

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Soluble inflammatory markers as predictors of hepatocellular damage and therapeutic response in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Chemokines: roles in leukocyte development, trafficking, and effector function

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Immunology of hepatitis B virus and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Diagnosis, management, and treatment of hepatitis C

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile.

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Virological response in patients with hepatitis C virus genotype 1b and a high viral load: impact of peginterferon-alpha-2a plus ribavirin dose reductions and host-related factors

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Serum and cerebral spinal fluid levels of chemokines and Th2 cytokines in Schistosoma mansoni myeloradiculopathy

1 reference

https://api.crossref.org/works/10.1590%2FS0074-02762011000100006

21 January 2018

Identifiers

10.1590/S0074-02762011000100006

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39275394&oldid=1817751293"